1. Home
  2. CBZ vs IDYA Comparison

CBZ vs IDYA Comparison

Compare CBZ & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBIZ Inc.

CBZ

CBIZ Inc.

HOLD

Current Price

$54.39

Market Cap

2.7B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$36.46

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBZ
IDYA
Founded
1987
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CBZ
IDYA
Price
$54.39
$36.46
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
$49.33
AVG Volume (30 Days)
502.5K
922.8K
Earning Date
02-25-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.66
N/A
Revenue
$2,675,607,000.00
$214,834,000.00
Revenue This Year
$55.67
$2,662.86
Revenue Next Year
$6.13
N/A
P/E Ratio
$32.02
N/A
Revenue Growth
59.19
5377.66
52 Week Low
$47.89
$13.45
52 Week High
$90.13
$39.28

Technical Indicators

Market Signals
Indicator
CBZ
IDYA
Relative Strength Index (RSI) 59.60 60.14
Support Level $52.46 $32.59
Resistance Level $54.42 $39.28
Average True Range (ATR) 1.59 1.43
MACD 0.19 0.17
Stochastic Oscillator 93.65 61.58

Price Performance

Historical Comparison
CBZ
IDYA

About CBZ CBIZ Inc.

CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: